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Malaria afﬂicts some 300–500million people and causes approx-
imately onemillion deaths per year, predominantly among children
under 5 years old and pregnant women. This parasite is becoming
resistant to most drugs currently used in the treatment of the
disease [1]. Efforts to tackle this problem are based on combined
therapies using drugs towhich the parasites have not yet developed
resistance, as well as toward identifying new drug targets [2].
Apicomplexa parasites possess an organelle called apicoplast,
acquired millions of years ago during an evolutionary event [3]. In
the case of malaria parasites, especially the most virulent
Plasmodium falciparum, a series of new ‘‘plantlike’’ enzymes was
recently discovered, some of which are associated with the
apicoplast [4].
Studies have shown that the shikimate [5,6] and methylerythr-
itol phosphate (MEP) [7,8] pathways present in the apicoplast are
active in the parasite. Recently, our group has shown that parasites
of P. falciparum biosynthesize two products that represent plantlike
pathways, namely, menaquinone [9] and carotenoids [10]. It is pos-
sible that other metabolic routes were retained and incorporated in
the parasite’s metabolism including the biosynthesis of vitamin E.
Vitamin E (group of tocopherols and tocotrienols) biosynthesis is
an attractive target for investigation since the P. falciparum liveschemical Societies. Published by E
f Parasitology, Institute of
eu Prestes 1374, CEP 05508-
.in a pro-oxidant environment and must therefore have an efﬁcient
antioxidant defense in order to ensure its survival. Vitamin E acts as
an antioxidant and free-radical scavenger and, together with other
antioxidants, has a role in the defense against oxidative stress [11].
In plants, vitamin E protects thylakoid components from oxidative
damage and also plays roles in electron transport reactions, cell
membrane permeability and ﬂuidity, and thus acts as a membrane
stabilizer [12].
This study showed for the ﬁrst time, an active pathway for the
vitamin E biosynthesis in P. falciparum employing a biochemical
approach. The results also demonstrated that this biosynthesis
can be inhibited by usnic acid and affects the lipid peroxidation
of infected erythrocytes. Because animals do not possess plastids,
knowledge on metabolic routes present in apicoplast represents
an opportunity to target these parasites rationally with therapies
that are relatively harmless to mammalian hosts.2. Materials and methods
2.1. Reagents
Percoll was purchased from Pharmacia (Uppsala, Sweden).
[1-(n)-3H]geranylgeranyl pyrophosphate triammonium salt
([1-(n)-3H]GGPP) (14 Ci/mmol, 1 mCi/ml) and [1-(n)-3H]farnesyl
pyrophosphate triammonium salt ([1-(n)-3H]FPP) (16 Ci/mmol,
200 lCi/mL) were obtained from Amersham-Pharmacia Biotech
(Buckinghamshire, UK). GibcoBRLife Technologies (Carlsbad, CA,
USA) supplied Albumax I. All solvents used were HPLC grade orlsevier B.V. All rights reserved.
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acid, butylated hydroxytoluene (BHT), Chlorotrimethylsilane
(TMCS),N,O-Bis(trimethylsilyl)triﬂuoroacetamide (BSTFA), Cumene
hydroperoxide (CumOOH) and usnic acid were purchased from Sig-
ma and Fluka. The 9,11,13,15-octadecatetraenoic acid (cis-parinaric
acid, (cPnA)) was purchased from Molecular Probes – Invitrogen.
2.2. P. falciparum culture
The P. falciparum clone 3D7 was cultured in vitro according to
the method of Trager and Jensen [13] where human sera was
substituted by Albumax I (0.5%) [14]. A gas mixture of 5% CO2,
5% O2, and 90% N2 was injected into bottles of 75 cm3. In some of
the experiments, the parasite was cultured under high oxygen
pressure of 5% CO2, 20% O2, and 75% N2. The cultures (approxi-
mately 15% parasitemia) were initially synchronized in ring stages
(1–10 h after invasion) by two treatments with 5% (w/v) D-sorbitol
solution in water. The parasites were maintained in culture until
the development of trophozoite (20–24 h after reinvasion) or
schizont (30–35 h after reinvasion) stages then synchronized with
Plasmagel [15]. Asynchronous cultures were puriﬁed on a 40%/
70%/80% discontinuous Percoll gradient and stored in liquid nitro-
gen. Parasite development was monitored by daily microscopic
evaluation of Giemsa-stained thin smears. We conducted the PCR
for mycoplasma detection to assure that parasite cultures are not
contaminated [16].
2.3. Metabolic labeling
Synchronous cultures of P. falciparum were labeled with
[1-(n)-3H]GGPP (3.125 lCi/ml) or [1-(n)-3H]FPP (3.125 lCi/ml) in
normal RPMI 1640 medium at ring, trophozoite or schizont stages
(20% parasitemia) for 10–14 h and were then recovered at tropho-
zoite, schizont and ring stages, respectively. Subsequently, the
parasite cultures were centrifuged at 800xg for 10 min at room
temperature. The intraerythrocytic stages were puriﬁed as de-
scribed above and each was submitted to vitamin E extraction.
To serve as a control, the same procedure was carried out with
uninfected erythrocytes.
2.4. Vitamin E extraction
A 1 mL volume of deionized water was added to 1.5  109
amounts of infected erythrocytes (300lL) in glass tubes. Cell lyses
was performed by sonication (three pulses of 10 s at 50 W, at 4 C)
and proteins were precipitated by adding 200 ll of ethanol (0.01%
BHT). After mixing for 1 min in a vortex, 2 mL of n-hexane (0.01%
BHT) was added. The sample was mixed for 1 min on a vortex
and centrifuged at 2700xg for 20 min at 4 C. The supernatant
was transferred to a glass tube and evaporated in a stream of nitro-
gen at room temperature. The residue was resuspended in 500 ll
of mobile phase – system dependent – and subjected to puriﬁca-
tion by RP-HPLC [17,18] and/or mass spectrometry techniques
[19].
2.5. Reversed phase high performance liquid chromatography
(RP-HPLC)
Hexane extracts were analyzed on a Phenomenex Luna C18 col-
umn (250 mm  4.6 mm  5 lm) (Phenomenex, CA, USA) coupled
with a C18 pre-column (Phenomenex, CA, USA), a UV Gilson 152/
UV–vis detector or a Diode Array detector (DAD) Gilson 170 and
a FC203B fraction collector. The software used for data processing
was the UniPoint LC™ 3.0 Software System.
Two different systems of RP-HPLC were employed for puriﬁca-
tion of vitamin E from parasite extracts. Protocol I entailed theuse of an isocratic solvent system based on methanol:acetoni-
trile:tetrahydrofuran (75:20:5) at a ﬂow of 0.6 ml/min [17]. Proto-
col II used a gradient solvent system based on methanol (solvent A)
and acetonitrile (solvent B). The mobile phase was 50/50% (A/B) at
0 min and the proportion between the solvents was subsequently
increased to 30/70% (A/B) at 28 min. The proportion returned to
50/50% (A/B) at 30 min with a ﬂow of 1 ml/min [18].
In experiments employing metabolically labeled precursors,
fractions per minute were collected. The resulting fractions were
dried, resuspended in 600 ll of liquid scintillation mixture (Perkin-
Elmer Life Sciences) and monitored with a Beckman 5000 b-radia-
tion scintillation counter (Beckman, CA, USA).
2.6. Mass-spectrometry analyses
A mass spectrometer electron impact Gas Chromatography –
Mass Spectrometry (GC–MS) – model Trace GC and mass
spectrometer Y2 K ion trap (MS) PolarisQ System (Finnigan,
ThermoQUEST Inc., San Jose, CA), comprising a data analysis pro-
gram (Xcalibur version 1.3) was used. The device was equipped
with a column of 30 m 0.25 mm OV-5 ms 0.25 micron (Ohio Valley,
USA). The parameters for the GC were injector temperature of
230 C, equipped with a splitless liner, and kept at an initial oven
temperature of 70 C for 4 min before being ramped to 310 C at
a rate of 15 C/min. This temperature was maintained for 3 min
and then cooled to initial conditions. The transfer line was main-
tained at 295 C and helium ﬂow was 1 ml/min. The mass spec-
trometer was operated in positive mode with ion source at
200 C. Two segments of acquisition were used. The ﬁrst was mon-
itored by a window of m/z 50–650 (Fullscan). The second segment
consisted of monitoring the fragmentation (MS2) of ions m/z 502
(a-tocopherol) and 488 (c-tocopherol) derivatized with trimethyl-
silane (TMS). The excitation energy scale for fragmentation was
0.30 and 1.20 V. The monitored fragment ions of a-tocopherol
were m/z 236, 237 and 277 and of c-tocopherol were m/z 222,
223, 263. Peaks coincident with retention time of a and c-tocoph-
erol obtained by RP-HPLC (Protocol II) for extracts of schizont
stages were derivatized as described by Van Pelt, 1998 [19] and
analyzed under the conditions described above.
2.7. Inhibition tests with usnic acid
The method described by Desjardins [20] was used to deter-
mine the inhibitory concentration of 50% (IC50) of growth of the
parasites. Seven different concentrations of usnic acid and two
controls, one without the drug and another with the vehicle only
were used. Another test was conducted to evaluate whether the
inhibition of parasite growth caused by usnic acid was reversible.
First, a-tocopherol was diluted in DMSO and then serially diluted
in culture medium. These concentrations were added to cultures
of treated cells with IC50 of usnic acid. Thin smears were performed
daily to control parasitemia level.
After determination of IC50, the parasite culture was treated
with the drug for a total of 48 h and labeled with radioactive pre-
cursor [1-(n)-3H]GGPP in the presence of usnic acid for the last
12 h. Biosynthesis of vitamin E was compared between the same
amounts of treated and untreated parasites by metabolic labeling
and RP-HPLC analysis (Protocol II).
2.8. Determination of tocopherol function as an antioxidant defence
Fluorometric measurements of cPnA were performed on a spec-
troﬂuorometer (model F4500, HITACHI) at 25 C under constant
stirring. The incorporation of the cPnA probe was initiated by add-
ing 20 ll of cPnA stock solution (224 mmol/l in ethanol) to a sus-
pension of 1  107 of infected or uninfected erythrocytes in PBS.
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312 nm and emission 455 nm, with a window of 5 and 20 nm,
respectively. Polymethacrylate 3 mL buckets with four translucent
sides were used (1.27  1.27  4.45 cm). The assay commenced by
taking a reading using a suspension of 2 ml of infected or unin-
fected erythrocytes in PBS with a hematocrit of 2% to obtain the
base signal. After 90 s a volume of 20 ll of the cPnA ethanolic solu-
tion was added. When the ﬂuorescence reached its maximum, 5 ll
of the CumOOH stock solution was added (200 mmol/l in ethanol).
The addition of the pro-oxidant was taken as time zero and from
this point, the decrease in ﬂuorescence after 6, 9 and 12 min was
calculated, deducting the base signal at the beginning of the read-
ing [21].
3. Results
3.1. Biosynthesis of vitamin E in all intraerythrocytic stages of P.
falciparum
The a and c-tocopherol biosynthesized by P. falciparum was
identiﬁed by two RP-HPLC systems. The radioactivity incorporation
proﬁle of parasite extracts was analyzed by the RP-HPLC (Protocol
II) and a radioactive fraction with a coincident retention time with
a-tocopherol (16 min) and c-tocopherol (23 min) standards was
detected for all intraerythrocytic stages metabolically labeled with
[1-(n)-3H]GGPP representing 0.4% of total vitamin E content
(Fig. 1). Furthermore, a radioactive fraction was detected in the
retention time of menaquinone-4 (12 min) standard as well as an-
other unknown peak. A higher level of vitamin E biosynthesis was
detected in schizont stages compared with trophozoite and ring
stages. Using another radioactive precursor [1-(n)-3H]FPP
(Fig. S1A) and/or another RP-HPLC system (Fig. S1B), a radioactive
fraction which had a coincident retention time with a and c-
tocopherol standards was detected in all intraerythrocytic stages.
Peaks with retention times coincident with a and b-carotenes stan-
dards were also detected [10]. No radioactive fraction coincident
with both vitamin E isomers was detected in uninfected erythro-
cytes (Fig. S1B).MK-4
-
Fig. 1. Radioactive elution proﬁle of the three intraerythrocytic stages of P. falciparumme
schizont stages (109 parasites) were puriﬁed by RP-HPLC (Protocol II). The retention times
4: menaquinone-4, a-T: a-tocopherol, c-T: c-tocopherol, ?: unknown.3.2. Identiﬁcation of a and c-tocopherol by GS-MS in schizont stages of
P. falciparum
In addition to metabolic labeling, quantitative and qualitative
GC–MS analysis was employed for RP-HPLC fractions (Protocol II)
of unlabelled infected and uninfected erythrocytes. To serve as a
control, culture medium was also analyzed (data not shown). Figs.
2A and 2D show the chromatogram and fragmentation spectra of a
and c-tocopherol standards, respectively. The fragment ions of a-
tocopherol at m/z 236 and 237, and of c-tocopherol at m/z 222
and 223, correspond to the benzene portion with or without a pro-
ton, whereas the fragment ion of a-tocopherol atm/z 277 and of c-
tocopherol at m/z 263 correspond to the benzene portion plus the
cyclized portion of the phytyl side chain. Both isomers of vitamin E
and their fragment ions were detected in infected erythrocytes
(Figs. 2B and E). In uninfected erythrocytes, only a-tocopherol
(Fig. 2C) and its fragment ions were detected, albeit at a 20-fold
lower concentration than in infected erythrocytes (Table. S1).
3.3. Usnic acid treatment inhibits vitamin E biosynthesis in P.
falciparum
Parasite growth was inhibited in a concentration-dependent
manner with an IC50 value of 24.6 ± 7 lM of usnic acid at 48 h of
treatment (Fig. 3A). This growth inhibition was partially reversed
in a dose-dependent manner by addition of a-tocopherol
(Fig. 3B), the target product assumed to have been inhibited. A stat-
ically signiﬁcant difference was observed between ‘‘IC50’’ and
‘‘[75 lM]a-T+I C50’’ (P < 0.05) and no signiﬁcant difference be-
tween ‘‘[75 lM]a-T+IC50’’ with ‘‘Control’’ (P > 0.05). In the group
where was added ‘‘[1 lM]a-T+IC50’’, no signiﬁcant difference
was observed compared with ‘‘IC50’’ (P > 0.05), (Fig. 3B). This ﬁnd-
ing suggests that vitamin E biosynthesis is commonly used by the
parasite and that usnic acid affects it, although we can not discard
the possibility that the usnic acid is affecting other functions in the
parasite.
The effect of usnic acid on vitamin E biosynthesis in the
schizont stage was further investigated. A decrease of 53.5 ± 7%
in a-tocopherol biosynthesis, and 34.5 ± 9% in c-tocopherolT
-T
?
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Fig. 2. Molecular identiﬁcation of a and c-tocopherol biosynthesis in schizont stages of P. falciparum by GC–MS/MS. Chromatograms and mass spectra from (A) a-tocopherol
standard; (B and C) HPLC peaks from 1.25  1010 parasites and 1.25  1010 uninfected erythrocytes, respectively. (D) c-tocopherol standard, (E and F) HPLC peaks from
1.25  1010 parasites and 1.25  1010 uninfected erythrocytes, respectively. All samples were previously puriﬁed by RP-HPLC (Protocol II). The molecular structure was
conﬁrmed by comparing the retention time of GC and the MS2 spectrum of the parental ions at m/z 502 and 488 for a and c-tocopherol, respectively.
3988 R.A.C. Sussmann et al. / FEBS Letters 585 (2011) 3985–3991biosynthesis was detected when the parasites were treated with
the IC50 of usnic acid for 48 h (Fig. 3C).
3.4. The role of vitamin E in P. falciparum
To test whether vitamin E biosynthesis in P. falciparum
parasites changes under high oxygen pressure, the parasite wasmaintained under an oxygen tension of 20% for 48 h and com-
pared with parasites kept under normal conditions. The proﬁle
of radioactive incorporation under high oxygen tension was in-
creased by 40.3 ± 12% for a-tocopherol and exhibited no signiﬁ-
cant difference for c-tocopherol, compared to control parasites.
Importantly, the parasites growth were the same in both culture
conditions (Fig. 4).
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Fig. 3. Inhibition of vitamin E biosynthesis in 48-h usnic acid treated parasites. (A) Usnic acid inhibited parasite growth in a concentration-dependent manner (IC50
24.6 ± 7 lM). (B) Parasite growth inhibition by usnic acid was partially reversed by the addition of a-tocopherol at different concentrations. (C) Radioactive elution proﬁle of
schizont stage treated or untreated for 48 h with usnic acid and labeled with [1-(n)-3H]GGPP in the last 16 h. MK-4: menaquinone-4, a-T: a-tocopherol, c-T: c-tocopherol, ?:
unknown. ⁄Statistically signiﬁcant difference (P < 0.05).
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Fig. 4. Effect on vitamin E biosynthesis by P. falciparum under higher O2 pressure. Radioa
a higher O2 pressure and labeled in the last 16 h with [1-(n)-3H]GGPP. The effect of high
under normal conditions and an increase of 40.3 ± 12% (n = 3). MK-4: menaquinone-4, a
Table 1
Lipid peroxidation assay I. Non-infected and infected erythrocytes cultivatedin 5%
(control) or 20% of oxygen were challenged by cumene hydroperoxide. Peroxidation
was estimated by the decrease in ﬂuorescence of cis parinaric acid.
% Of decrease in ﬂuorescence after
6 min 9 min 12 min
Non-infected erythrocytes
Control 20% 30.05 ± 2.49 11.62 ± 1.15 4.65 ± 3.36
O2 32.60 ± 1 .75 14.00 ± 4.15 2.90 ± 2.89
Infected erythrocytes
Control 35.00 ± 1 .63 9.93 ± 1 .37 2.41 ± 1.03
20% O2 45.50 ± 1.90* 8.48 ± 1 .68* 4.48 ± 0.68
* P < 0.05 differ signiﬁcantly from control (ANOVA).
R.A.C. Sussmann et al. / FEBS Letters 585 (2011) 3985–3991 3989Moreover, lipid peroxidation in parasites cultivated under 20%
oxygen tension was 67 ± 1.4% lower than in parasites cultivated
under normal conditions. This ﬁnding could be explained by higher
biosynthesis of vitamin E in parasites cultivated under 20% oxygen
tension. No difference in cPna oxidation was found in non-infected
erythrocytes (Table 1).
To conﬁrm that vitamin E biosynthesis exerted an inﬂuence on
lipid peroxidation, parasites treated and untreated with usnic acid
were compared (Table 2). The treatment of uninfected erythrocytes
with usnic acid did not signiﬁcantly affect cPnA oxidation com-
pared with untreated erythrocytes. On the other hand, in treated
infected erythrocytes, cPnA oxidation increased 15.3 ± 1.7%actions
-T
-T
?
ctive elution proﬁle by RP-HPLC (Protocol II) of schizont stage maintained for 48 h at
er O2 pressure on vitamin E biosynthesis was compared with parasites maintained
-T: a-tocopherol, c-T: c-tocopherol, ?: unknown.
Table 2
Lipid peroxidation assay II. Non-infected and infected erythrocytes submitted to
culturing conditions in absence or presence of 25 lm of usnic acid and in absence or
presence of a-tocopherol/ascorbic acid were challenged by cumene hydroperoxide.
Peroxidation was estimated by the decrease in ﬂuorescence of cis-parinaric acid.
% Of decrease in ﬂuorescence after
6 min 9 min 12 min
Non-infected erythrocytes
Control 46.70 ± 3.91 31.20 ± 4.40 9.00 ± 2.65
25 lm of usnic acid 50.53 ± 3.60 27.80 ± 2.00 11.13 ± 3.78
750 nM of a-tocopherol 73.16 ± 3.41* 49.80 ± 1.47* 25.16 ± 2.22*
750 nM of ascorbic acid 59.65 ± 6.00 29.40 ± 1.27 8.6 ± 0.42
Infected erythrocytes
Control 71.85 ± 3.11 42.90 ± 1.96 14.42 ± 0.97
25 lm of usnic acid⁄⁄ 61.00 ± 2.68* 27.57 ± 1.51* 7.00 ± 1.86*
25 lm of usnic acid + 750 nM
of a-tocopherol
70.83 ± 1.50 56.16 ± 3.71 43.10 ± 4.41
25 lm of usnic acid + 750 nM
of ascorbic acid
64.33 ± 1.97* 28.33 ± 2.81* 10.16 ± 2.17*
* P < 0.05 differ signiﬁcantly from control (ANOVA).
 P < 0.05 differ signiﬁcantly from **(ANOVA).
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of the addition of exogenous a-tocopherol or ascorbic acid was
analyzed. The addition of a-tocopherol to infected erythrocytes
treated with usnic acid prevented cPnA oxidation by 28.5 ± 2.6%.
When ascorbic acid was added to infected or uninfected erythro-
cytes, no oxidation protection of cPnA was observed (Table 2).
4. Discussion
The present study shows for the ﬁrst time that the parasite P. fal-
ciparumbiosynthesizes vitaminE.Hitherto, the literature has shown
this biosynthesis to have occurred exclusively in photosynthetic
eukaryotes. Using two different methods of RP-HPLC and metabolic
labeling with precursors [1-(n)-3H]GGPP or [1-(n)-3H]FPP, two
radioactive peaks with the same retention time as a and c-tocoph-
erol were identiﬁed in the three intraerythrocytic stages of the par-
asite. The structure of these isomers was conﬁrmed by GC–MS/MS,
removing any doubt as to the identiﬁcation of themetabolic labeled
compound. Also byGC–MS/MS20-fold higher levels ofa-tocopherol
were found in infected erythrocytes compared with uninfected
erythrocytes. The opposite was detected by Simões et al. where in-
fected erythrocytes had lower amount of a-tocopherol [22]. How-
ever, the authors employed human serum instead Albumax, and is
known that serum contains vitamin E. Intriguingly, c-tocopherol
was found only in infected erythrocytes. The presence of c-tocoph-
erol in infected erythrocytes and its absence in non-infected eryth-
rocytes provides further evidence that the metabolic pathway for
vitamin E biosynthesis is active in P. falciparum, since this isomer
is an intermediate compound for the formation of a-tocopherol as
shown in metabolic pathways of Arabidopsis sp. [23] and Syn-
echocysts sp [24].
To test the importance of vitamin E biosynthesis for the para-
site, the parasite was treated with usnic acid, an inhibitor of
hydroxyphenylpyruvate dioxygenase, the enzyme that catalyzes
the conversion of p-hydroxyphenylpyruvic acid to homogentisic
acid [25], a precursor of vitamin E biosynthesis [26]. Norris et al.
and Dahnhardt et al. showed that vitamin E biosynthesis is dis-
rupted in mutants that lack the encoding gene of hydroxyphenyl-
pyruvate dioxygenase [26,27].
Parasites of P. falciparum showed growth inhibition upon drug
treatment. Moreover, this inhibition could be partially reversed
by the addition of a-tocopherol, suggesting that vitamin E biosyn-
thesis is commonly used by the malaria parasite and that usnic
acid affects this speciﬁcally. The decrease of vitamin E biosynthe-sis, but not of menaquinone, when parasites are treated with usnic
acid suggest inhibitory activity of usnic acid on hydroxyphenylpy-
ruvate dioxygenase as described by Meazza et al. [28].
The antimalarial activity of usnic acid has previously been
tested in a P. falciparum K1 strain with an IC50 of 15 lM [29]
and studies in the literature have found that usnic acid also shows
activity against leishmania [30] and trypanosoma [31].
The parasites of P. falciparum live in a pro-oxidant environment
that contains oxygen and iron, the key prerequisites for the forma-
tion of reactive oxygen species via the Fenton reaction, and there-
fore have evolved extensive detoxifying and protective
mechanisms, which both limit the production of and potential
damage by ROS. However, tocopherol can efﬁciently quench O2
and scavenge various radicals released during oxidative stress
[11]. As a ﬁrst step toward elucidating the role of tocopherol in par-
asites of P. falciparum, the parasites were cultivated under 20% oxy-
gen tension and an increase in vitamin E biosynthesis was
observed. A gas mixture without oxygen was also tested and vita-
min E biosynthesis did not change (data not shown). A study
involving the Euglena gracilis W14ZUL strain, reported that an or-
ganic carbon source resulted in increased mitochondrial activity,
reactive oxygen species and tocopherol biosynthesis [32]. Another
group has also shown increased vitamin E biosynthesis [33] in Ros-
marinus ofﬁcinalis L. under water stress, when photosynthesis is
limited and activated oxygen formation is higher. Our hypothesis
is that the same phenomenon is occurring in P. falciparum as a re-
sponse to a higher oxygen tension.
In photosynthetic eukaryotes, tocopherol plays important roles
in protecting photosynthetic membranes and we assessed whether
tocopherol can protect infected membranes from lipid peroxida-
tion. The study results show that when parasites undergo in-
creased biosynthesis of vitamin E (under 20% oxygen tension) the
membranes are protected from lipid peroxidation. By contrast,
when parasites are treated with usnic acid, lipid peroxidation is in-
creased. Simões et al. [22] using the similar approach showed that
erythrocytes infected with P. falciparum present the major resis-
tance to a lipoperoxidation than uninfected erythrocytes, similar
to ours results. Maeda et al. [34] challenged tocopherol-deﬁcient
mutants of the Synechocystis sp. strain PCC 6803 (slr1737 and
slr1736) with different combinations of chemicals and/or abiotic
stresses to induce the formation of different types of reactive oxy-
gen species. The study showed that, compared with the wild type,
mutants of Synechocystis sp challenged with linolenic acid (18:3)
and high luminosity, accumulated a higher level of lipid peroxides.
Moreover, in the wild type under the same conditions, the level of
tocopherols had doubled. The same applies to tocopherol-deﬁcient
mutants of Arabidopsis thaliana (vte1 and vte2), unable to biosyn-
thesize tocopherols, showed lipid peroxides levels 4 and 100 times
greater, respectively, compared to wild type under conditions of
oxidative stress. Lack of vitamin E biosynthesis also leads to
growth defects during seed germination [35]. These results con-
ﬁrmed that tocopherols play a signiﬁcant role as a lipophilic anti-
oxidant in Synechocystis sp and Arabidopsis thaliana.
Akin to the growth recovery assay, the exogenous addition of a-
tocopherol caused a decrease in lipid peroxidation among infected
erythrocytes treated with the IC50 of usnic acid for 48 h. The addi-
tion of exogenous ascorbic acid had no effect on lipid peroxidation.
In visceral leishmaniasis caused by Leishmania donovani, Biswas
et al. [36] described an increase in lipid peroxidation in erythro-
cytes from infected hamsters, which culminated in hemolysis
and anemia. Sen et al. [37] subsequently showed that the suscep-
tibility to lipid peroxidation of erythrocytes of hamsters infected
with L. donovani can be attenuated by oral administration of
2 mg/kg a-tocopherol twice a week for three months. The results
given in Tables 1 and 2 suggest that a-tocopherol protects the
intraerythrocytic stages of P. falciparum from lipid peroxidation.
R.A.C. Sussmann et al. / FEBS Letters 585 (2011) 3985–3991 3991In conclusion, the intraerythrocytic stages of P. falciparum have
an active pathway for biosynthesis of vitamin E. In photosynthetic
eukaryotes, tocopherols are found in plastids while biosynthesis
takes place on the inner envelope membrane of chloroplasts. Fur-
ther in-depth biochemical analyses are required to elucidate where
the biosynthesis takes place and to determine the precise roles of
tocopherol in P. falciparum. Based on these results, a new drug tar-
get is proposed for the development of antimalarial.
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